Copeptin in the differential diagnosis of hypotonic polyuria
- PMID: 31368050
- DOI: 10.1007/s40618-019-01087-6
Copeptin in the differential diagnosis of hypotonic polyuria
Abstract
Copeptin: Copeptin is secreted in equimolar amount to Arginine Vasopressin (AVP) but can easily be measured with a sandwich immunoassay. Both peptides, copeptin and AVP, show a high correlation. Accordingly, copeptin mirrors the amount of AVP in the circulation and its measurement provides an attractive marker in the differential diagnosis of diabetes insipidus.
The polyuria polydipsia syndrome: Diabetes insipidus-either central or nephrogenic-has to be differentiated from primary polydipsia. Differentiation is crucial since wrong treatment can have deleterious consequences. Since many decades, the "gold standard" for differential diagnosis has been the classical water deprivation test, which has several limitations leading to an overall limited diagnostic accuracy. In addition, the test has a long duration of 17 hours and is cumbersome for patients. Clinical signs and symptoms as well as MRI characteristics overlap between patients with diabetes insipidus and primary polydipsia. Direct measurement of AVP upon osmotic stimulation was first shown to overcome these limitations, but failed to enter clinical practice mainly due to technical limitations of the AVP assay.
Copeptin as diagnostic tool in the polyuria polydipsia syndrome: We have recently shown that copeptin, without prior water deprivation, identifies patients with nephrogenic diabetes insipidus. On the other hand, for the more difficult differentiation between central diabetes insipidus and primary polydipsia, a copeptin level of 4.9 pmol/L stimulated with hypertonic saline infusion differentiates between these two entities with a high diagnostic accuracy, and is superior to the water deprivation test. It is important to note that close sodium monitoring during the hypertonic saline test is a prerequisite.
Conclusion: Therefore, we propose that copeptin upon hypertonic saline infusion should become the new standard test in the differential diagnosis of diabetes insipidus.
Keywords: Diabetes insipidus; Differential diagnosis; Primary polydipsia.
Comment in
-
Urinary symptoms: broadening the horizons for the copeptin assay.J Endocrinol Invest. 2020 Jan;43(1):119-120. doi: 10.1007/s40618-019-01142-2. Epub 2019 Nov 12. J Endocrinol Invest. 2020. PMID: 31721086 No abstract available.
Similar articles
-
EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome.Eur J Endocrinol. 2019 Jul;181(1):R11-R21. doi: 10.1530/EJE-19-0163. Eur J Endocrinol. 2019. PMID: 31067508 Free PMC article. Review.
-
Diabetes Insipidus: New Concepts for Diagnosis.Neuroendocrinology. 2020;110(9-10):859-867. doi: 10.1159/000505548. Epub 2020 Jan 2. Neuroendocrinology. 2020. PMID: 31986514 Review.
-
Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.J Clin Endocrinol Metab. 2015 Jun;100(6):2268-74. doi: 10.1210/jc.2014-4507. Epub 2015 Mar 13. J Clin Endocrinol Metab. 2015. PMID: 25768671
-
Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.Arch Pediatr. 2018 Jan;25(1):45-47. doi: 10.1016/j.arcped.2017.11.010. Epub 2017 Dec 11. Arch Pediatr. 2018. PMID: 29241593
-
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.N Engl J Med. 2018 Aug 2;379(5):428-439. doi: 10.1056/NEJMoa1803760. N Engl J Med. 2018. PMID: 30067922
Cited by
-
Recurrent Severe Hyponatremia Following Polyethylene Glycol Electrolyte Lavage Solution with Ascorbic Acid in a Patient with Undiagnosed Syndrome of Inappropriate Antidiuretic Hormone Secretion.Am J Case Rep. 2025 Aug 5;26:e948355. doi: 10.12659/AJCR.948355. Am J Case Rep. 2025. PMID: 40760784 Free PMC article.
-
Copeptin: a neuroendocrine biomarker of COVID-19 severity.Biomark Med. 2022 Jun;16(8):589-597. doi: 10.2217/bmm-2021-1100. Epub 2022 Mar 30. Biomark Med. 2022. PMID: 35350852 Free PMC article.
-
Usefulness of non-stimulated copeptin in the diagnosis of diabetes insipidus after pituitary surgery.J Endocrinol Invest. 2021 Oct;44(10):2315-2317. doi: 10.1007/s40618-021-01530-7. Epub 2021 Feb 20. J Endocrinol Invest. 2021. PMID: 33609279 No abstract available.
-
Disease activity score is associated with vertebral fragility fractures in patients with rheumatoid arthritis: a cross-sectional multidisciplinary study.Rheumatol Int. 2025 May 2;45(5):133. doi: 10.1007/s00296-025-05877-5. Rheumatol Int. 2025. PMID: 40314774
-
A New Biomarker Copeptin in Determining Disease Severity in COVID-19.Infect Dis Clin Microbiol. 2024 Sep 26;6(3):225-232. doi: 10.36519/idcm.2024.324. eCollection 2024 Sep. Infect Dis Clin Microbiol. 2024. PMID: 39403104 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous